OR WAIT 15 SECS
India’s bioeconomy has grown 16x within a decade from $10 billion to $165+ billion between 2014-2024 and...
The Andhra Pradesh MedTech Zone (AMTZ) is spearheading the BRICS BioDesign Programme to advance healthcare inn...
Fifteen startups and four student teams were announced as the winners of the 9th edition of C-CAMP’s Nat...
Digital Bioprocessing Tools Powering Indian Pharma
Much like digital technologies have become an indispensable part of everyday life, they are now transforming one of the world's most tightly regulated industries: pharmaceuticals. For decades, Indian drug manufacturers built their global reputation on cost-efficient production and large-scale manufacturing. Today, however, competitiveness is increasingly being defined by digital capabilities. From Manufacturing Execution Systems (MES) and electronic batch records to Laboratory Information Management Systems (LIMS), artificial intelligence (AI), predictive maintenance and smart factory technologies, pharmaceutical companies are digitising manufacturing operations to improve quality, strengthen regulatory compliance, reduce production costs and accelerate time to market. According to Archimedis Digital's State of Digital Transformation in Indian Pharma 2025 (Quality Edition), more than 88 per cent of Indian pharmaceutical companies have initiated digital transformation in quality functions, with one-third already achieving significant or enterprise-level maturity. As India's pharmaceutical industry moves beyond traditional manufacturing towards Pharma 4.0, we explore the digital bioprocessing technologies driving this transformation, the companies leading the shift, and the tools that are becoming essential for building the next generation of smart biomanufacturing facilities.For Feedback, please email us at: communications@mmactiv.com
